CR CR mol REL Time IMATINIB % unmutated BCR-ABL % mutated BCR-ABL Chemotherapy Proportion of Mutant BCR-ABL Alleles in Relation to Treatment Response of de novo Ph+ALL H.Pfeifer,O.G.Ottmann
{"Image DocumentName": "Adult ALL \u2013 therapeutic strategies, including Burkitt", "Image ImageDescription": "and Lymphoblastic Lymphomas. D.Hoelzer. J.W.Goethe University. Frankfurt. for the GMALL Study Group. German Multicenter Studies for Adult Acute Lymphoblastic Leukemia. Caesarea, April", "Image XResolution": "37", "Image YResolution": "37", "Image ResolutionUnit": "Pixels/Centimeter", "Image Software": "SlidePlayer", "Image YCbCrPositioning": "Centered"}